ARCHIVES

Ovarian Suppression Treatment Plus Tamoxifen Can Lower Recurrence Risk

This article is from The Cancer Letter archive.

Vol. 37 No. 12 | December 26, 2014

Download PDF Visit The Full Archive

Related Articles

ASCO Guideline Aims To Improve Hormone Receptor Testing

April 23, 2010

Complaints Are “Astonishingly Far From Facts,” But NCI May Be Leaving Good Science Unfunded

April 29, 1977

Hopkins Investigator Dies In Fall From Denver Hotel Window

May 27, 1977

FDA Approves Afinitor For Advanced Kidney Cancer

March 27, 2009

Clinical Sciences Director Liu To Head Singapore Program.

January 12, 2001

In Brief: Tormey To Replace Carbone As ECOG chairman; Bishop Delivers First B.J. Kennedy Lecture

November 2, 1990